Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report

Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report

IntroductionClozapine and chlorpromazine are widely used for treating schizophrenia. However, irregular medical follow-ups are common in patients with schizophrenia, potentially leading to long-term super-dose medication. Managing such cases poses significant challenges for clinical psychiatrists.Ca...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaobo Xie, Jinzhang Chen, Hongli Song, Zebin Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Psychiatry
Subjects:	clozapine chlorpromazine antipsychotics schizophrenia case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1533350/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A cross-sectional study to analyze the pattern of pharmacotherapy and its associated factors among patients with schizophrenia
by: B. S. Abhishree, et al.
Published: (2024-12-01)

Study of factors associated with obesity in patients using antipsychotics in schizophrenia
by: Vishalakshi Patnam, et al.
Published: (2024-12-01)

Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
by: Mulualem Kelebie, et al.
Published: (2025-02-01)

Clozapine-induced hypertension: A paradox
by: Hamza Hussain, et al.
Published: (2024-12-01)

Disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy
by: Dhandapani Nandakumar, et al.
Published: (2023-06-01)

Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders
by: Bole Cvetka Bačar, et al.
Published: (2017-03-01)

Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
by: Ramandeep Kaur, et al.
Published: (2023-04-01)

Depot Versus Oral Antipsychotics in Patients with Schizophrenia: Which is Better on Side Effects, Functional Improvement, and Life Satisfaction
by: İlknur Kiraz Avcı, et al.
Published: (2024-07-01)

Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment
by: O.O. Khaustova, et al.
Published: (2024-04-01)

The effects of clinical and pharmacological factors on the ratio of clozapine to norclozapine in psychiatric patients
by: Anna Mach, et al.
Published: (2025-01-01)

Prevalence of obsessive-compulsive symptoms in patients with schizophrenia treated with clozapine: a scoping review
by: Evelyn Moreno Tarazona, et al.
Published: (2025-01-01)

Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
by: Letizia Biso, et al.
Published: (2025-01-01)

Association between treatment resistance and cognitive function in schizophrenia
by: Jiaqian Sun, et al.
Published: (2024-10-01)

Antipsychotic-induced hyperprolactinemia: Toxicologic mechanism and the increased breast cancer risk
by: Steven B. Bird
Published: (2025-06-01)

Changes in the pharmacokinetics of lurasidone in a pregnant woman with schizophrenia
by: Mihoko Kawai, et al.
Published: (2024-12-01)

IUPHAR themed review: The gut microbiome in schizophrenia
by: Srinivas Kamath, et al.
Published: (2025-01-01)

Prevalence and factors associated with high risk for obstructive sleep apnea in schizophrenia spectrum disorder patients on long-term clozapine
by: Rika Rijal, et al.
Published: (2024-12-01)

Pathology of single dose cadmium toxicity and investigations of protective effect of simultaneous chlorpromazine administrations in rats
by: Tuna Erdem, et al.

The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force
by: Hélène Verdoux, et al.
Published: (2025-01-01)

Expression study of Wnt/β-catenin signaling pathway associated lncRNAs in schizophrenia
by: Fatemeh Manafzadeh, et al.
Published: (2025-01-01)

Effect of Atypical Antipsychotic Usage at Therapeutic Doses on Daytime Sleepiness
by: Birol Topcu, et al.
Published: (2023-09-01)

Bilingual side effect: a case of foreign language syndrome following chlorpromazine-induced neuroleptic malignant syndrome
by: Sanja Andric Petrovic, et al.
Published: (2025-01-01)

Experience with and attitude toward clozapine use among patients receiving clozapine on long term and their caregivers
by: Sandeep Grover, et al.
Published: (2023-11-01)

Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting
by: Christoph U. Correll, et al.
Published: (2025-01-01)

Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
by: Miquel Bernardo, et al.
Published: (2025-01-01)

Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01)

Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis [version 2; peer review: 1 approved, 2 approved with reservations]
by: Spyridon Siafis, et al.
Published: (2025-01-01)

The Role of Neuroglia in the Development and Progression of Schizophrenia
by: Neha S. Rawani, et al.
Published: (2024-12-01)

THE INFLUENCE OF SCHIZOPHRENIA ON DENTAL TREATMENT
by: Oana Cristina Cretu, et al.
Published: (2024-10-01)

Determination Of Physical Activity Level In The Caregiving Of Schizophrenia Patients
by: Sefa Lok, et al.
Published: (2020-04-01)

Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children
by: Sophie A. Kitchen, et al.
Published: (2025-02-01)

Schizophrenia and Nicotine - A Bittersweet Psychiatric Story
by: Satrajit Ghosal, et al.
Published: (2025-01-01)

Quality of life in persons with schizophrenia
by: Zack Cernovsky
Published: (2017-03-01)

Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
by: Soumitra Ghosh, et al.
Published: (2023-09-01)

Dropout rates and reasons for dropout among patients receiving clozapine
by: Sandeep Grover, et al.
Published: (2023-06-01)

IDENTIFICATION OF CHARACTERISTICS OF SCHIZOPHRENIA PATIENTS IN MENTAL HOSPITAL
by: Rindayati Rindayati, et al.
Published: (2024-10-01)

The Safety of Ondansetron and Chlorpromazine for Hyperemesis Gravidarum in First Trimester Pregnancy
by: Şafak Özdemirci, et al.
Published: (2014-08-01)

The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
by: Indah Kurnia Utami, et al.
Published: (2024-11-01)

Patient-reported outcome measures to assess mental and physical health status, functionality, and quality of life in patients with major depression or schizophrenia
by: Luis San, et al.
Published: (2025-01-01)

Gratitude in the recovery process: perspectives of women and men with schizophrenia
by: Iwona Michalczuk, et al.
Published: (2024-11-01)